Jay Bhattacharya

Jay Bhattacharya
Official portrait, 2025
18th Director of the National Institutes of Health
Assumed office
April 1, 2025
PresidentDonald Trump
DeputyMatthew Memoli
Preceded byMonica Bertagnolli
Acting Director of the Centers for Disease Control and Prevention
In office
February 18, 2026 – August 12, 2026
PresidentDonald Trump
Preceded byJim O'Neill
Succeeded byErica Schwartz
Personal details
BornJayanta Bhattacharya
1968 (age 57–58)
Kolkata, India
EducationStanford University (BA, MA, MD, PhD)
Known for
Great Barrington Declaration
Scientific career
FieldsBiomedicine, econometrics, health economics
WorkplacesStanford University
ThesisLifetime returns to specialization in medicine (2000)
Thomas MaCurdy

Jayanta Bhattacharya (born 1968) is an American health economist, trained as a physician, who has served as the 18th director of the National Institutes of Health since 2025. Bhattacharya had additionally served as the acting director of the Centers for Disease Control and Prevention since.

Bhattacharya earned his M.D. and Ph.D. in economics from Stanford University. He does not practice medicine but specializes in health economics. Bhattacharya was a professor of medicine, economics, and health research policy at Stanford University until March 2025, when he left his position and became an emeritus professor so that he could start his position at the National Institutes of Health (NIH). He also was an investigator at Stanford's Center for Demography and Economics of Health and Aging whose research focused on the economics of health care. In November 2024, President Donald Trump named Bhattacharya as his choice to lead the NIH, and he was confirmed by the United States Senate on March 25, 2025.

Bhattacharya is the first Indian American to lead the NIH. He opposed the lockdowns and mask mandates imposed in 2020 as a response to the COVID-19 pandemic. With Martin Kulldorff and Sunetra Gupta, he was a co-author in 2020 of the Great Barrington Declaration, which advocated lifting COVID-19 restrictions on lower-risk groups to develop herd immunity through widespread infection, while promoting the fringe notion that vulnerable people could be simultaneously protected from the virus.